Patent 12083270 was granted and assigned to OptiNose on September, 2024 by the United States Patent and Trademark Office.
A nasal delivery device for and method of delivering substance to the middle meatus in a nasal cavity of a subject in the treatment of a condition, in particular an inflammatory or infectious condition, thereof, the delivery device comprising: a nosepiece unit (